Pharmacological properties of naftopidil, a drug for treatment of the bladder outlet obstruction for patients with benign prostatic hyperplasia

Folia Pharmacologica Japonica

Volumn 116, Issue 2, 2000, Pages 63-69

  Ikegaki, I ^a  

^a ASAHI CHEMICAL INDUSTRY CO   (Japan)

Author keywords

Benign prostatic hyperplasia; Naftopidil; Orthostatic hypotension; Prostate pressure; 1 Adrenoceptor antagonist

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; NAFTOPIDIL; PRAZOSIN; PROSTATE SPECIFIC ANTIGEN; TAMSULOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLADDER NECK STENOSIS; BLOOD PRESSURE; CONTROLLED STUDY; DOG; DOSE TIME EFFECT RELATION; MEAN ARTERIAL PRESSURE; NONHUMAN; ORTHOSTATIC HYPERTENSION; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; REVIEW;

EID: 0033831323     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.116.63     Document Type: Review

References (31)

1. Dynamics of acute retention in prostatic patients and role of adrenergic receptors
2. Epidemiology and natural history of benign prostatic hyperplasia
3. A neurohistochemical and histological study of peripheral autonomic neurons of the human bladder neck and prostate
4. Autonomic innervation of the human prostate
5. Alpha-adrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy
6. In vitro characterization of the α-adrenoceptors in human prostate
7. A pharmacological study on α adrenergic receptor subtypes in smooth muscle of human urinary bladder base and prostatic urethra
8. Pharmacological profile of the novel α-adrenoceptor antagonist KT-611 (Naftopidil)
9. Binding characteristics of naftopidil and α 1-adrenoceptor antagonists to prostatic α-adrenoceptors in benign prostatic hypertrophy
10. International Union of Pharmacology, X. Recommendation for nomenclature of alpha 1-adrenoceptors: Consensus update
11. Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor
12. Solution-phase library screening for the identification of rare clones: Isolation of an α 1-D-adrenergic receptor cDNA
13. Cloning, functional expression and tissue distribution of human cDNA for the α 1c-adrenergic receptor
14. Cloning, functional expression and tissure distribution of human α 1C-adrenoceptor splice variants
15. Detection of α 1-adrenoceptor subtypes in human hypertrophied prostate by in situ hybridization
16. Decreased blood pressure response in mice deficient of the α 1b-adrenergic receptor
17. Naftopidil, a novel α 1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human α 1-adrenoceptors
18. Use of recombinant α 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy
19. Effect of α 1-adrenoceptor antagonists in dog prostate/blood pressure models
20. Evaluation of the pharmacological selectivity profile of α1 adrenoceptor antagonists at prostatic α1 adrenoceptors: Binding, functional and in vivo studies
21. Effects of selective and nonselective alpha-1- adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs
22. The α 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human α1c subtype
23. Nomenclature and state of the art on alpha1-adrenoceptors
24. Vascular α 1-adrenoceptor subtype selectivity and α1-blocker-induced orthostatic hypotension
25. Characterization of the mouse alpha1D-adrenergic receptor gene